日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer

对于不适合接受顺铂治疗的肌层浸润性膀胱癌患者,新辅助纳武利尤单抗联合或不联合伊匹木单抗治疗

Guercio, Brendan J; Pietzak, Eugene J; Ravichandran, Vignesh; Chen, Jie-Fu; Shah, Ronak H; Peters, Vanessa; Regazzi, Ashley M; Niglio, Scot A; Aggen, David H; Funt, Samuel A; Donahue, Timothy F; Goh, Alvin C; Cha, Eugene K; Wong, Phillip; Richards, Allison L; Cobbs, Cassidy C; Donat, S Machele; Dalbagni, Guido; Bochner, Bernard H; Iyer, Gopa; Donoghue, Mark T A; Ostrovnaya, Irina; Al-Ahmadie, Hikmat A; Rosenberg, Jonathan E; Teo, Min Yuen

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

辅助性帕博利珠单抗治疗与观察治疗肌层浸润性尿路上皮癌的比较

Apolo, Andrea B; Ballman, Karla V; Sonpavde, Guru; Berg, Stephanie; Kim, William Y; Parikh, Rahul; Teo, Min Yuen; Sweis, Randy F; Geynisman, Daniel M; Grivas, Petros; Chatta, Gurkamal; Reichert, Zachery Roger; Kim, Joseph W; Bilen, Mehmet Asim; McGregor, Bradley; Singh, Parminder; Tripathi, Abhishek; Cole, Suzanne; Simon, Nicholas; Niglio, Scot; Ley, Lisa; Cordes, Lisa; Srinivas, Sandy; Huang, Jiaoti; Odegaard, Meagan; Watt, Colleen; Petrylak, Daniel; Hoffman-Censits, Jeannie; Wen, Yujia; Hahn, Olwen; Mitchell, Cecilia; Tan, Alan; Streicher, Howard; Sharon, Elad; Moon, Helen; Woods, Michael; Halabi, Susan; Perez Burbano, Gabriela; Morris, Michael J; Rosenberg, Jonathan E

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer.

调节 PPARγ 通路可上调 NECTIN4,并增强嵌合抗原受体 (CAR) T 细胞疗法在膀胱癌中的疗效

Chang Kevin, Delavan Henry M, Yip Elizabeth, Kasap Corynn, Zhu Jun, Lodha Roshan, Liao Sheng-You, Berman Sarah C, Carretero-Gonzalez Alberto, Basar Merve, Gokturk Ozcan Gamze, Teo Min Yuen, Solit David B, Rosenberg Jonathan E, Al-Ahmadie Hikmat, Ding Cornelia C K, Chan Emily, Steri Veronica, Porten Sima P, Koshkin Vadim S, Friedlander Terence W, Feng Felix Y, Lee John K, Wiita Arun P, Chu Carissa E, Chou Jonathan

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

尿路上皮癌不同组织学亚型的临床结果、基因组异质性和治疗考量

Chu, Carissa E; Chen, Ziyu; Whiting, Karissa; Ostrovnaya, Irina; Lenis, Andrew T; Clinton, Timothy N; Rammal, Rayan; Ozcan, Gamze Gokturk; Akbulut, Dilara; Basar, Merve; Chen, Jie-Fu; Chen, Ying-Bei; Gopalan, Anuradha; Fine, Samson W; Tickoo, Satish K; Arcila, Maria; Brannon, A Rose; Berger, Michael F; Cha, Eugene K; Goh, Alvin C; Donahue, Timothy F; Bajorin, Dean F; Teo, Min Yuen; Rosenberg, Jonathan E; Iyer, Gopa; Pietzak, Eugene J; Bochner, Bernard H; Reuter, Victor E; Sarungbam, Judy; Solit, David B; Al-Ahmadie, Hikmat

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

化疗耐药性肌层浸润性膀胱癌的自然史和基因组图谱

Lenis, Andrew T; Whiting, Karissa; Ravichandran, Vignesh; Tallman, Jacob E; Alam, Syed M; Chu, Carissa E; Jesus Escano, Manual De; Bochner, Emily; Katims, Andrew; Reisz, Peter A; Truong, Hong; Clinton, Timothy N; Telis, Leon; Dason, Shawn; McPherson, Victor; Teo, Min Yuen; Funt, Samuel; Aggen, David; Goh, Alvin C; Donahue, Timothy F; Cha, Eugene K; Donat, S Machele; Herr, Harry W; Dalbagni, Guido; Schultz, Nikolaus; Berger, Michael F; Bajorin, Dean F; Rosenberg, Jonathan E; Bochner, Bernard H; Ostrovnaya, Irina; Al-Ahmadie, Hikmat; Solit, David B; Iyer, Gopa; Pietzak, Eugene J

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

NEUROD1、ASCL1 和 POU2F3 的差异表达定义了膀胱小细胞/神经内分泌癌的分子亚型及其预后意义

Akbulut, Dilara; Whiting, Karissa; Teo, Min-Yuen; Tallman, Jacob E; Ozcan, Gamze Gokturk; Basar, Merve; Jia, Liwei; Rammal, Rayan; Chen, Jie-Fu; Sarungbam, Judy; Chen, Ying-Bei; Gopalan, Anuradha; Fine, Samson W; Tickoo, Satish K; Mehra, Rohit; Baine, Marina; Bochner, Bernard H; Pietzak, Eugene J; Bajorin, Dean F; Rosenberg, Jonathan E; Iyer, Gopa; Solit, David B; Reuter, Victor E; Rekhtman, Natasha; Ostrovnaya, Irina; Al-Ahmadie, Hikmat

Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis

免疫检查点抑制剂和酪氨酸激酶抑制剂联合用药在实体瘤中的毒性:系统评价和荟萃分析

O'Reilly, David; O'Leary, Caroline L; Reilly, Aislinn; Teo, Min Yuen; O'Kane, Grainne; Hendriks, Lizza; Bennett, Kathleen; Naidoo, Jarushka

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

FGFR3 改变的尿路上皮癌的临床和基因组特征及厄达替尼治疗结果:一项真实世界研究

Guercio, Brendan J; Sarfaty, Michal; Teo, Min Yuen; Ratna, Neha; Duzgol, Cihan; Funt, Samuel A; Lee, Chung-Han; Aggen, David H; Regazzi, Ashley M; Chen, Ziyu; Lattanzi, Michael; Al-Ahmadie, Hikmat A; Brannon, A Rose; Shah, Ronak; Chu, Carissa; Lenis, Andrew T; Pietzak, Eugene; Bochner, Bernard H; Berger, Michael F; Solit, David B; Rosenberg, Jonathan E; Bajorin, Dean F; Iyer, Gopa

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

伊布替尼联合疗法治疗晚期尿路上皮癌的1b/2期研究结果

Mar, Nataliya; Zakharia, Yousef; Falcon, Alejandro; Morales-Barrera, Rafael; Mellado, Begona; Duran, Ignacio; Oh, Do-Youn; Williamson, Stephen K; Gajate, Pablo; Arkenau, Hendrik-Tobias; Jones, Robert J; Teo, Min Yuen; Turan, Tolga; McLaughlin, Robert T; Peltier, Hillary M; Chong, Elizabeth; Atluri, Harisha; Dean, James P; Castellano, Daniel

Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer

低分割放射治疗(Hypo-RT)治疗局限性膀胱癌

Moore, Assaf; Lobaugh, Stephanie M; Zhang, Zhigang; Rosenberg, Jonathan E; Iyer, Gopa; Teo, Min Yuen; Bochner, Bernard; Donahue, Timothy; Nunez, David Aramburu; Dreyfuss, Alexandra; Gorovets, Daniel; Zelefsky, Michael J; Kollmeier, Marisa A